Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Pyrimidine nucleoside analogs in cancer treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. j Gun
1997 · External reference
Gemcitabine: current status of Phase I and II trials. j Clin
1994 · External reference
10.1016/0163-7258(92)90022-r
10.1016/0163-7258(92)90022-r · External reference
10.1038/sj.leu.2402114
10.1038/sj.leu.2402114 · External reference
Unresolved reference
External reference
Nucleoside transporters: molecular biology and implications for therapeutic development. Mal Med
1999 · External reference
10.1016/s0021-9258(19)38732-0
10.1016/s0021-9258(19)38732-0 · External reference
10.1080/15257770008033018
10.1080/15257770008033018 · External reference
The role of nucleoside transport in anticancer drug resistance. Drug Resist
1998 · External reference
Unresolved reference
External reference
10.1016/s1470-2045(02)00788-x
10.1016/s1470-2045(02)00788-x · External reference
10.3109/10428199809059245
10.3109/10428199809059245 · External reference
10.1172/jci110472
10.1172/jci110472 · External reference
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia
1983 · External reference
Unresolved reference
External reference
10.1182/blood.v98.6.1922
10.1182/blood.v98.6.1922 · External reference
10.1073/pnas.78.5.3235
10.1073/pnas.78.5.3235 · External reference
10.1016/0006-2952(82)90266-0
10.1016/0006-2952(82)90266-0 · External reference
10.3727/095535490820873921
10.3727/095535490820873921 · External reference
Unresolved reference
External reference
Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia
1987 · External reference
10.1001/archinte.1984.00350210198035
10.1001/archinte.1984.00350210198035 · External reference
10.1200/jco.1991.9.4.679
10.1200/jco.1991.9.4.679 · External reference
Mechanism of drug release from multivesicular liposomes
1996 · External reference
Unresolved reference
External reference
10.1345/aph.19347
10.1345/aph.19347 · External reference
10.1038/clpt.1984.120
10.1038/clpt.1984.120 · External reference
10.1001/archneur.1995.00540330094020
10.1001/archneur.1995.00540330094020 · External reference
10.1200/jco.1993.11.11.2186
10.1200/jco.1993.11.11.2186 · External reference
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
1999 · External reference
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. j Clin
1999 · External reference
Unresolved reference
External reference
O'Day SJ et al An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis
2002 · External reference
10.1248/cpb.28.2915
10.1248/cpb.28.2915 · External reference
10.1016/0006-2952(90)90514-l
10.1016/0006-2952(90)90514-l · External reference
Unresolved reference
External reference
10.1038/sj.leu.2401152
10.1038/sj.leu.2401152 · External reference
Unresolved reference
External reference
10.1046/j.1365-2141.2001.03141.x
10.1046/j.1365-2141.2001.03141.x · External reference
10.1016/s0145-2126(00)00036-9
10.1016/s0145-2126(00)00036-9 · External reference
Unresolved reference
External reference
10.1159/000226979
10.1159/000226979 · External reference
A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group
1994 · External reference
Unresolved reference
External reference
10.1021/jm00110a019
10.1021/jm00110a019 · External reference
A Phase I clinical, plasma and cellular pharmacology study of gemcitabine
1991 · External reference
Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine
1996 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/s0014-2999(98)00883-8
10.1016/s0014-2999(98)00883-8 · External reference
Unresolved reference
External reference
10.1016/0006-2952(92)90077-v
10.1016/0006-2952(92)90077-v · External reference
10.1016/0006-2952(93)90566-f
10.1016/0006-2952(93)90566-f · External reference
10.1023/a:1008368624555
10.1023/a:1008368624555 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1046/j.1365-2141.2001.02795.x
10.1046/j.1365-2141.2001.02795.x · External reference
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. j Clin
2001 · External reference
Unresolved reference
External reference
10.1093/oxfordjournals.annonc.a059018
10.1093/oxfordjournals.annonc.a059018 · External reference
Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a Phase II study
1994 · External reference
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a Phase II study
1994 · External reference
Cisplatin—gemcitabine combination in advanced non-small-cell lung cancer: a Phase Ilstudy.J Gun
1997 · External reference
Unresolved reference
External reference
Advanced breast cancer: a Phase II trial with gemcitabine. j Clin
1995 · External reference
10.1093/oxfordjournals.annonc.a058775
10.1093/oxfordjournals.annonc.a058775 · External reference
10.1006/gyno.1996.0284
10.1006/gyno.1996.0284 · External reference
10.1093/jnci/86.20.1530
10.1093/jnci/86.20.1530 · External reference
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analog, in solid-tumor and leukemic cell lines
2001 · External reference
10.1074/jbc.270.39.23055
10.1074/jbc.270.39.23055 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a Phase I and pharmacokinetic study in patients with advanced solid malignancies. j Clin
2002 · External reference
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia. j Clin
2001 · External reference
Unresolved reference
External reference
10.1200/jco.2002.12.047
10.1200/jco.2002.12.047 · External reference
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia. j Clin
2002 · External reference
Phase II Study of troxacitabine in chemotherapy naive patients with advanced cancer of the pancreas
2002 · External reference
10.1200/jco.2003.03.057
10.1200/jco.2003.03.057 · External reference
Unresolved reference
External reference
Randomized Phase I/II study of troxacitabine combined with cytarabine, idarubicin or topotecan in patients with refractory myeloid leukemias. I Clin
2003 · External reference
10.1200/jco.2003.11.016
10.1200/jco.2003.11.016 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1124/mol.61.1.222
10.1124/mol.61.1.222 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1006/excr.1996.0007
10.1006/excr.1996.0007 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1002/(sici)1097-0215(19990105)80:1<155::aid-ijc27>3.0.co;2-a
10.1002/(sici)1097-0215(19990105)80:1<155::aid-ijc27>3.0.co;2-a · External reference
10.1023/a:1006126212481
10.1023/a:1006126212481 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1002/cncr.11273
10.1002/cncr.11273 · External reference
10.1038/362849a0
10.1038/362849a0 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/s0021-9258(19)68144-5
10.1016/s0021-9258(19)68144-5 · External reference
Unresolved reference
External reference
10.7326/0003-4819-85-2-237
10.7326/0003-4819-85-2-237 · External reference
10.1016/0006-2952(77)90132-0
10.1016/0006-2952(77)90132-0 · External reference
10.1126/science.6254144
10.1126/science.6254144 · External reference
10.1016/0045-6039(84)90033-2
10.1016/0045-6039(84)90033-2 · External reference
10.1016/s0145-2126(98)00020-4
10.1016/s0145-2126(98)00020-4 · External reference
10.1200/jco.2002.04.117
10.1200/jco.2002.04.117 · External reference
Unresolved reference
External reference
Cellular differentiation, cytidine analogs and DNA methylation
1980 · External reference
10.1007/978-3-642-59696-4_9
10.1007/978-3-642-59696-4_9 · External reference
Unresolved reference
External reference
10.1016/0163-7258(89)90022-3
10.1016/0163-7258(89)90022-3 · External reference
10.1200/jco.2000.18.5.956
10.1200/jco.2000.18.5.956 · External reference
10.1002/(sici)1097-0142(19991215)86:12<2632::aid-cncr7>3.0.co;2-a
10.1002/(sici)1097-0142(19991215)86:12<2632::aid-cncr7>3.0.co;2-a · External reference
10.1038/sj.leu.2400796
10.1038/sj.leu.2400796 · External reference
Huijgens PC, Neve P Continuous infusion of low-dose 5-aza-2--deoxycytidine in elderly patients with high-risk myelodysplastic syndrome
1997 · External reference
10.1007/bf00300235
10.1007/bf00300235 · External reference
10.1007/bf00694333
10.1007/bf00694333 · External reference
Antimetabolites. Cancer Chemother
1999 · External reference
10.1007/bf01275480
10.1007/bf01275480 · External reference
Unresolved reference
External reference
